Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07678021Not yet recruiting
Randomised, open-label trial in coronary artery disease (CAD) and left ventricular dysfunction (2 arms), sponsored by National Center for Cardiovascular Disease. Primary endpoint: Major Adverse Cardiovascular and Cerebrovascular Events at 1 year. Planned start Aug 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07678021.